nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—pancreatic cancer—duodenum cancer	0.858	1	CtDrD
Sunitinib—DAPK3—pancreas—duodenum cancer	0.0006	0.00469	CbGeAlD
Sunitinib—PRPF4B—digestive system—duodenum cancer	0.000599	0.00468	CbGeAlD
Sunitinib—PDGFRB—gall bladder—duodenum cancer	0.000596	0.00465	CbGeAlD
Sunitinib—PHKG1—endocrine gland—duodenum cancer	0.000594	0.00464	CbGeAlD
Sunitinib—DAPK1—endocrine gland—duodenum cancer	0.000594	0.00464	CbGeAlD
Sunitinib—CSNK2A1—digestive system—duodenum cancer	0.000583	0.00455	CbGeAlD
Sunitinib—STK11—endocrine gland—duodenum cancer	0.000576	0.0045	CbGeAlD
Sunitinib—BRD4—endocrine gland—duodenum cancer	0.000576	0.0045	CbGeAlD
Sunitinib—MYLK—digestive system—duodenum cancer	0.000575	0.00449	CbGeAlD
Sunitinib—STK4—digestive system—duodenum cancer	0.000564	0.00441	CbGeAlD
Sunitinib—MARK2—endocrine gland—duodenum cancer	0.000559	0.00436	CbGeAlD
Sunitinib—SGK3—endocrine gland—duodenum cancer	0.000554	0.00432	CbGeAlD
Sunitinib—ICK—endocrine gland—duodenum cancer	0.000549	0.00428	CbGeAlD
Sunitinib—MAP4K4—pancreas—duodenum cancer	0.000539	0.00421	CbGeAlD
Sunitinib—STK16—digestive system—duodenum cancer	0.000536	0.00419	CbGeAlD
Sunitinib—NUAK2—pancreas—duodenum cancer	0.000535	0.00418	CbGeAlD
Sunitinib—HIPK3—digestive system—duodenum cancer	0.000533	0.00417	CbGeAlD
Sunitinib—HIPK2—digestive system—duodenum cancer	0.000533	0.00417	CbGeAlD
Sunitinib—ALK—digestive system—duodenum cancer	0.000533	0.00417	CbGeAlD
Sunitinib—INSR—endocrine gland—duodenum cancer	0.000525	0.0041	CbGeAlD
Sunitinib—OXSR1—endocrine gland—duodenum cancer	0.000525	0.0041	CbGeAlD
Sunitinib—SNRK—endocrine gland—duodenum cancer	0.000525	0.0041	CbGeAlD
Sunitinib—RPS6KA3—pancreas—duodenum cancer	0.000524	0.00409	CbGeAlD
Sunitinib—PRKAA2—lymph node—duodenum cancer	0.00052	0.00406	CbGeAlD
Sunitinib—STK38—endocrine gland—duodenum cancer	0.000517	0.00404	CbGeAlD
Sunitinib—RPS6KA2—endocrine gland—duodenum cancer	0.000517	0.00404	CbGeAlD
Sunitinib—CSNK1A1—pancreas—duodenum cancer	0.000514	0.00401	CbGeAlD
Sunitinib—AURKC—endocrine gland—duodenum cancer	0.000513	0.00401	CbGeAlD
Sunitinib—CLK1—pancreas—duodenum cancer	0.00051	0.00399	CbGeAlD
Sunitinib—CSNK1G2—endocrine gland—duodenum cancer	0.000509	0.00398	CbGeAlD
Sunitinib—PKN1—endocrine gland—duodenum cancer	0.000509	0.00398	CbGeAlD
Sunitinib—PRPF4—endocrine gland—duodenum cancer	0.000502	0.00392	CbGeAlD
Sunitinib—CAMK2G—pancreas—duodenum cancer	0.000501	0.00391	CbGeAlD
Sunitinib—STK17B—lymph node—duodenum cancer	0.0005	0.00391	CbGeAlD
Sunitinib—PRPF4B—endocrine gland—duodenum cancer	0.000495	0.00386	CbGeAlD
Sunitinib—ROCK1—digestive system—duodenum cancer	0.000492	0.00384	CbGeAlD
Sunitinib—PRKAA1—pancreas—duodenum cancer	0.000489	0.00382	CbGeAlD
Sunitinib—STK39—endocrine gland—duodenum cancer	0.000488	0.00381	CbGeAlD
Sunitinib—CSNK2A1—endocrine gland—duodenum cancer	0.000481	0.00376	CbGeAlD
Sunitinib—CSNK1E—pancreas—duodenum cancer	0.000476	0.00372	CbGeAlD
Sunitinib—MYLK—endocrine gland—duodenum cancer	0.000475	0.00371	CbGeAlD
Sunitinib—PLK4—endocrine gland—duodenum cancer	0.000469	0.00367	CbGeAlD
Sunitinib—STK4—endocrine gland—duodenum cancer	0.000466	0.00364	CbGeAlD
Sunitinib—STK17A—lymph node—duodenum cancer	0.000461	0.0036	CbGeAlD
Sunitinib—MAP4K4—digestive system—duodenum cancer	0.00046	0.00359	CbGeAlD
Sunitinib—PHKG2—endocrine gland—duodenum cancer	0.000458	0.00358	CbGeAlD
Sunitinib—MAP2K2—pancreas—duodenum cancer	0.000458	0.00358	CbGeAlD
Sunitinib—CDK14—lymph node—duodenum cancer	0.000454	0.00355	CbGeAlD
Sunitinib—LATS2—lymph node—duodenum cancer	0.000448	0.0035	CbGeAlD
Sunitinib—PAK3—lymph node—duodenum cancer	0.000448	0.0035	CbGeAlD
Sunitinib—CDK16—lymph node—duodenum cancer	0.000448	0.0035	CbGeAlD
Sunitinib—TBK1—pancreas—duodenum cancer	0.000445	0.00348	CbGeAlD
Sunitinib—MAP2K1—digestive system—duodenum cancer	0.000444	0.00347	CbGeAlD
Sunitinib—STK16—endocrine gland—duodenum cancer	0.000443	0.00346	CbGeAlD
Sunitinib—TYK2—pancreas—duodenum cancer	0.000442	0.00346	CbGeAlD
Sunitinib—RPS6KA5—lymph node—duodenum cancer	0.000442	0.00345	CbGeAlD
Sunitinib—TYRO3—endocrine gland—duodenum cancer	0.000441	0.00344	CbGeAlD
Sunitinib—HIPK3—endocrine gland—duodenum cancer	0.000441	0.00344	CbGeAlD
Sunitinib—HIPK2—endocrine gland—duodenum cancer	0.000441	0.00344	CbGeAlD
Sunitinib—ALK—endocrine gland—duodenum cancer	0.000441	0.00344	CbGeAlD
Sunitinib—CSNK1A1—digestive system—duodenum cancer	0.000439	0.00343	CbGeAlD
Sunitinib—IRAK1—pancreas—duodenum cancer	0.000437	0.00341	CbGeAlD
Sunitinib—TNK1—endocrine gland—duodenum cancer	0.000436	0.00341	CbGeAlD
Sunitinib—CLK1—digestive system—duodenum cancer	0.000436	0.0034	CbGeAlD
Sunitinib—RPS6KB1—pancreas—duodenum cancer	0.000429	0.00335	CbGeAlD
Sunitinib—CAMK2G—digestive system—duodenum cancer	0.000428	0.00334	CbGeAlD
Sunitinib—CLK4—lymph node—duodenum cancer	0.000425	0.00332	CbGeAlD
Sunitinib—DAPK3—endocrine gland—duodenum cancer	0.000424	0.00331	CbGeAlD
Sunitinib—SBK1—lymph node—duodenum cancer	0.00042	0.00328	CbGeAlD
Sunitinib—ITK—lymph node—duodenum cancer	0.00042	0.00328	CbGeAlD
Sunitinib—CLK2—endocrine gland—duodenum cancer	0.00042	0.00328	CbGeAlD
Sunitinib—PRKAA1—digestive system—duodenum cancer	0.000418	0.00326	CbGeAlD
Sunitinib—MAP4K2—endocrine gland—duodenum cancer	0.000418	0.00326	CbGeAlD
Sunitinib—BLK—lymph node—duodenum cancer	0.000416	0.00325	CbGeAlD
Sunitinib—PTK2B—digestive system—duodenum cancer	0.000413	0.00323	CbGeAlD
Sunitinib—PHKG1—lymph node—duodenum cancer	0.000411	0.00321	CbGeAlD
Sunitinib—DAPK1—lymph node—duodenum cancer	0.000411	0.00321	CbGeAlD
Sunitinib—SLK—pancreas—duodenum cancer	0.000408	0.00319	CbGeAlD
Sunitinib—ROCK1—endocrine gland—duodenum cancer	0.000407	0.00318	CbGeAlD
Sunitinib—CSNK1E—digestive system—duodenum cancer	0.000406	0.00317	CbGeAlD
Sunitinib—STK11—lymph node—duodenum cancer	0.000398	0.00311	CbGeAlD
Sunitinib—BRD4—lymph node—duodenum cancer	0.000398	0.00311	CbGeAlD
Sunitinib—DYRK1A—endocrine gland—duodenum cancer	0.000397	0.0031	CbGeAlD
Sunitinib—RPS6KA1—lymph node—duodenum cancer	0.000394	0.00308	CbGeAlD
Sunitinib—RIOK1—lymph node—duodenum cancer	0.000394	0.00308	CbGeAlD
Sunitinib—MAP2K2—digestive system—duodenum cancer	0.000391	0.00306	CbGeAlD
Sunitinib—ULK3—digestive system—duodenum cancer	0.000391	0.00306	CbGeAlD
Sunitinib—MAP4K5—pancreas—duodenum cancer	0.000388	0.00303	CbGeAlD
Sunitinib—MERTK—endocrine gland—duodenum cancer	0.000387	0.00303	CbGeAlD
Sunitinib—MARK2—lymph node—duodenum cancer	0.000386	0.00302	CbGeAlD
Sunitinib—TNIK—lymph node—duodenum cancer	0.000386	0.00302	CbGeAlD
Sunitinib—SGK3—lymph node—duodenum cancer	0.000383	0.00299	CbGeAlD
Sunitinib—TBK1—digestive system—duodenum cancer	0.00038	0.00297	CbGeAlD
Sunitinib—MAP4K4—endocrine gland—duodenum cancer	0.00038	0.00297	CbGeAlD
Sunitinib—ICK—lymph node—duodenum cancer	0.000379	0.00296	CbGeAlD
Sunitinib—TYK2—digestive system—duodenum cancer	0.000378	0.00295	CbGeAlD
Sunitinib—FLT1—pancreas—duodenum cancer	0.000375	0.00293	CbGeAlD
Sunitinib—FLT3—endocrine gland—duodenum cancer	0.000375	0.00293	CbGeAlD
Sunitinib—MAP3K12—endocrine gland—duodenum cancer	0.000375	0.00293	CbGeAlD
Sunitinib—RPS6KA3—endocrine gland—duodenum cancer	0.00037	0.00289	CbGeAlD
Sunitinib—CHEK2—Cell Cycle—MEN1—duodenum cancer	0.000367	0.0272	CbGpPWpGaD
Sunitinib—MAP2K1—endocrine gland—duodenum cancer	0.000367	0.00287	CbGeAlD
Sunitinib—CHEK2—lymph node—duodenum cancer	0.000366	0.00286	CbGeAlD
Sunitinib—NUAK1—lymph node—duodenum cancer	0.000366	0.00286	CbGeAlD
Sunitinib—RPS6KB1—digestive system—duodenum cancer	0.000366	0.00286	CbGeAlD
Sunitinib—FGR—digestive system—duodenum cancer	0.000364	0.00284	CbGeAlD
Sunitinib—RET—digestive system—duodenum cancer	0.000364	0.00284	CbGeAlD
Sunitinib—INSR—lymph node—duodenum cancer	0.000363	0.00284	CbGeAlD
Sunitinib—OXSR1—lymph node—duodenum cancer	0.000363	0.00284	CbGeAlD
Sunitinib—SNRK—lymph node—duodenum cancer	0.000363	0.00284	CbGeAlD
Sunitinib—CSNK1A1—endocrine gland—duodenum cancer	0.000362	0.00283	CbGeAlD
Sunitinib—CLK1—endocrine gland—duodenum cancer	0.00036	0.00281	CbGeAlD
Sunitinib—YES1—pancreas—duodenum cancer	0.000358	0.0028	CbGeAlD
Sunitinib—STK38—lymph node—duodenum cancer	0.000357	0.00279	CbGeAlD
Sunitinib—RPS6KA2—lymph node—duodenum cancer	0.000357	0.00279	CbGeAlD
Sunitinib—AURKC—lymph node—duodenum cancer	0.000355	0.00277	CbGeAlD
Sunitinib—TAOK3—pancreas—duodenum cancer	0.000354	0.00276	CbGeAlD
Sunitinib—CAMK2G—endocrine gland—duodenum cancer	0.000353	0.00276	CbGeAlD
Sunitinib—BMP2K—endocrine gland—duodenum cancer	0.000353	0.00276	CbGeAlD
Sunitinib—CSNK1G2—lymph node—duodenum cancer	0.000352	0.00275	CbGeAlD
Sunitinib—PKN1—lymph node—duodenum cancer	0.000352	0.00275	CbGeAlD
Sunitinib—LRRK2—endocrine gland—duodenum cancer	0.00035	0.00274	CbGeAlD
Sunitinib—PRPF4—lymph node—duodenum cancer	0.000347	0.00271	CbGeAlD
Sunitinib—FGFR2—digestive system—duodenum cancer	0.000346	0.0027	CbGeAlD
Sunitinib—PRKAA1—endocrine gland—duodenum cancer	0.000345	0.0027	CbGeAlD
Sunitinib—JAK2—digestive system—duodenum cancer	0.000344	0.00269	CbGeAlD
Sunitinib—PRPF4B—lymph node—duodenum cancer	0.000342	0.00267	CbGeAlD
Sunitinib—PTK2B—endocrine gland—duodenum cancer	0.000341	0.00267	CbGeAlD
Sunitinib—FLT4—endocrine gland—duodenum cancer	0.00034	0.00266	CbGeAlD
Sunitinib—FYN—digestive system—duodenum cancer	0.000339	0.00265	CbGeAlD
Sunitinib—STK39—lymph node—duodenum cancer	0.000337	0.00263	CbGeAlD
Sunitinib—CSNK1E—endocrine gland—duodenum cancer	0.000336	0.00262	CbGeAlD
Sunitinib—CSNK1G2—TCF dependent signaling in response to WNT—MEN1—duodenum cancer	0.000336	0.0249	CbGpPWpGaD
Sunitinib—CSNK2A1—lymph node—duodenum cancer	0.000333	0.0026	CbGeAlD
Sunitinib—MYLK—lymph node—duodenum cancer	0.000328	0.00257	CbGeAlD
Sunitinib—CSNK1G2—RNF mutants show enhanced WNT signaling and proliferation—MEN1—duodenum cancer	0.000325	0.0241	CbGpPWpGaD
Sunitinib—PLK4—lymph node—duodenum cancer	0.000324	0.00253	CbGeAlD
Sunitinib—MAP2K2—endocrine gland—duodenum cancer	0.000323	0.00253	CbGeAlD
Sunitinib—ULK3—endocrine gland—duodenum cancer	0.000323	0.00253	CbGeAlD
Sunitinib—STK4—lymph node—duodenum cancer	0.000322	0.00252	CbGeAlD
Sunitinib—MAP3K2—endocrine gland—duodenum cancer	0.000321	0.00251	CbGeAlD
Sunitinib—FLT1—digestive system—duodenum cancer	0.00032	0.0025	CbGeAlD
Sunitinib—PHKG2—lymph node—duodenum cancer	0.000317	0.00247	CbGeAlD
Sunitinib—STK24—lymph node—duodenum cancer	0.000315	0.00246	CbGeAlD
Sunitinib—TBK1—endocrine gland—duodenum cancer	0.000314	0.00246	CbGeAlD
Sunitinib—TYK2—endocrine gland—duodenum cancer	0.000312	0.00244	CbGeAlD
Sunitinib—DAPK2—lymph node—duodenum cancer	0.000311	0.00243	CbGeAlD
Sunitinib—STK16—lymph node—duodenum cancer	0.000306	0.00239	CbGeAlD
Sunitinib—YES1—digestive system—duodenum cancer	0.000306	0.00239	CbGeAlD
Sunitinib—HIPK3—lymph node—duodenum cancer	0.000305	0.00238	CbGeAlD
Sunitinib—ALK—lymph node—duodenum cancer	0.000305	0.00238	CbGeAlD
Sunitinib—HIPK2—lymph node—duodenum cancer	0.000305	0.00238	CbGeAlD
Sunitinib—STK10—digestive system—duodenum cancer	0.000303	0.00237	CbGeAlD
Sunitinib—RPS6KB1—endocrine gland—duodenum cancer	0.000302	0.00236	CbGeAlD
Sunitinib—TAOK3—digestive system—duodenum cancer	0.000302	0.00236	CbGeAlD
Sunitinib—CSNK1G2—Signaling by WNT in cancer—MEN1—duodenum cancer	0.000302	0.0224	CbGpPWpGaD
Sunitinib—RIOK2—lymph node—duodenum cancer	0.000302	0.00236	CbGeAlD
Sunitinib—TNK1—lymph node—duodenum cancer	0.000302	0.00236	CbGeAlD
Sunitinib—FGR—endocrine gland—duodenum cancer	0.000301	0.00235	CbGeAlD
Sunitinib—RET—endocrine gland—duodenum cancer	0.000301	0.00235	CbGeAlD
Sunitinib—PDGFRA—digestive system—duodenum cancer	0.0003	0.00234	CbGeAlD
Sunitinib—AXL—endocrine gland—duodenum cancer	0.000299	0.00234	CbGeAlD
Sunitinib—MAP4K1—lymph node—duodenum cancer	0.000299	0.00233	CbGeAlD
Sunitinib—DAPK3—lymph node—duodenum cancer	0.000293	0.00229	CbGeAlD
Sunitinib—CLK2—lymph node—duodenum cancer	0.00029	0.00227	CbGeAlD
Sunitinib—MAP4K2—lymph node—duodenum cancer	0.000289	0.00225	CbGeAlD
Sunitinib—CYP3A7—endocrine gland—duodenum cancer	0.000287	0.00224	CbGeAlD
Sunitinib—FGFR2—endocrine gland—duodenum cancer	0.000286	0.00223	CbGeAlD
Sunitinib—STK3—lymph node—duodenum cancer	0.000285	0.00222	CbGeAlD
Sunitinib—JAK2—endocrine gland—duodenum cancer	0.000284	0.00222	CbGeAlD
Sunitinib—KIT—pancreas—duodenum cancer	0.000281	0.00219	CbGeAlD
Sunitinib—FYN—endocrine gland—duodenum cancer	0.00028	0.00219	CbGeAlD
Sunitinib—PDGFRB—pancreas—duodenum cancer	0.000274	0.00214	CbGeAlD
Sunitinib—DYRK1A—lymph node—duodenum cancer	0.000274	0.00214	CbGeAlD
Sunitinib—MAP4K5—endocrine gland—duodenum cancer	0.000274	0.00214	CbGeAlD
Sunitinib—MAP3K3—endocrine gland—duodenum cancer	0.000274	0.00214	CbGeAlD
Sunitinib—RPS6KA2—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.000272	0.0201	CbGpPWpGaD
Sunitinib—KDR—digestive system—duodenum cancer	0.000271	0.00212	CbGeAlD
Sunitinib—MERTK—lymph node—duodenum cancer	0.000268	0.00209	CbGeAlD
Sunitinib—RET—SIDS Susceptibility Pathways—SST—duodenum cancer	0.000267	0.0198	CbGpPWpGaD
Sunitinib—CSNK2A1—TCF dependent signaling in response to WNT—MEN1—duodenum cancer	0.000266	0.0197	CbGpPWpGaD
Sunitinib—FLT1—endocrine gland—duodenum cancer	0.000265	0.00207	CbGeAlD
Sunitinib—CSF1R—digestive system—duodenum cancer	0.000264	0.00206	CbGeAlD
Sunitinib—MAP4K4—lymph node—duodenum cancer	0.000263	0.00205	CbGeAlD
Sunitinib—NUAK2—lymph node—duodenum cancer	0.000261	0.00204	CbGeAlD
Sunitinib—FLT3—lymph node—duodenum cancer	0.000259	0.00202	CbGeAlD
Sunitinib—MAP3K12—lymph node—duodenum cancer	0.000259	0.00202	CbGeAlD
Sunitinib—CSNK2A1—RNF mutants show enhanced WNT signaling and proliferation—MEN1—duodenum cancer	0.000258	0.0191	CbGpPWpGaD
Sunitinib—RPS6KA3—lymph node—duodenum cancer	0.000256	0.002	CbGeAlD
Sunitinib—MAP2K1—lymph node—duodenum cancer	0.000254	0.00198	CbGeAlD
Sunitinib—YES1—endocrine gland—duodenum cancer	0.000253	0.00197	CbGeAlD
Sunitinib—STK10—endocrine gland—duodenum cancer	0.000251	0.00196	CbGeAlD
Sunitinib—CSNK1A1—lymph node—duodenum cancer	0.000251	0.00196	CbGeAlD
Sunitinib—TAOK3—endocrine gland—duodenum cancer	0.00025	0.00195	CbGeAlD
Sunitinib—CLK1—lymph node—duodenum cancer	0.000249	0.00194	CbGeAlD
Sunitinib—CSNK1G2—Signaling by Wnt—MEN1—duodenum cancer	0.000249	0.0184	CbGpPWpGaD
Sunitinib—PDGFRA—endocrine gland—duodenum cancer	0.000248	0.00194	CbGeAlD
Sunitinib—BMP2K—lymph node—duodenum cancer	0.000244	0.00191	CbGeAlD
Sunitinib—CAMK2G—lymph node—duodenum cancer	0.000244	0.00191	CbGeAlD
Sunitinib—RPS6KA1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.000244	0.0181	CbGpPWpGaD
Sunitinib—LRRK2—lymph node—duodenum cancer	0.000242	0.00189	CbGeAlD
Sunitinib—KIT—digestive system—duodenum cancer	0.00024	0.00187	CbGeAlD
Sunitinib—CSNK2A1—Signaling by WNT in cancer—MEN1—duodenum cancer	0.000239	0.0177	CbGpPWpGaD
Sunitinib—PRKAA1—lymph node—duodenum cancer	0.000239	0.00186	CbGeAlD
Sunitinib—PTK2B—lymph node—duodenum cancer	0.000236	0.00184	CbGeAlD
Sunitinib—FLT4—lymph node—duodenum cancer	0.000235	0.00184	CbGeAlD
Sunitinib—PDGFRB—digestive system—duodenum cancer	0.000234	0.00183	CbGeAlD
Sunitinib—CSNK1E—lymph node—duodenum cancer	0.000232	0.00181	CbGeAlD
Sunitinib—FGFR1—lymph node—duodenum cancer	0.000232	0.00181	CbGeAlD
Sunitinib—IRAK4—lymph node—duodenum cancer	0.000229	0.00179	CbGeAlD
Sunitinib—KDR—endocrine gland—duodenum cancer	0.000224	0.00175	CbGeAlD
Sunitinib—MAP2K5—endocrine gland—duodenum cancer	0.000224	0.00175	CbGeAlD
Sunitinib—MAP2K2—lymph node—duodenum cancer	0.000223	0.00175	CbGeAlD
Sunitinib—ULK3—lymph node—duodenum cancer	0.000223	0.00175	CbGeAlD
Sunitinib—MAP3K2—lymph node—duodenum cancer	0.000222	0.00173	CbGeAlD
Sunitinib—MAP3K7—lymph node—duodenum cancer	0.00022	0.00172	CbGeAlD
Sunitinib—ABCC4—pancreas—duodenum cancer	0.000219	0.00171	CbGeAlD
Sunitinib—CSF1R—endocrine gland—duodenum cancer	0.000218	0.00171	CbGeAlD
Sunitinib—TBK1—lymph node—duodenum cancer	0.000217	0.0017	CbGeAlD
Sunitinib—TYK2—lymph node—duodenum cancer	0.000216	0.00169	CbGeAlD
Sunitinib—IRAK1—lymph node—duodenum cancer	0.000213	0.00166	CbGeAlD
Sunitinib—CSNK1A1—TCF dependent signaling in response to WNT—MEN1—duodenum cancer	0.000212	0.0157	CbGpPWpGaD
Sunitinib—RPS6KB1—lymph node—duodenum cancer	0.000209	0.00163	CbGeAlD
Sunitinib—RET—lymph node—duodenum cancer	0.000208	0.00162	CbGeAlD
Sunitinib—FGR—lymph node—duodenum cancer	0.000208	0.00162	CbGeAlD
Sunitinib—AXL—lymph node—duodenum cancer	0.000207	0.00162	CbGeAlD
Sunitinib—CSNK1A1—RNF mutants show enhanced WNT signaling and proliferation—MEN1—duodenum cancer	0.000206	0.0152	CbGpPWpGaD
Sunitinib—SLK—lymph node—duodenum cancer	0.000199	0.00156	CbGeAlD
Sunitinib—KIT—endocrine gland—duodenum cancer	0.000198	0.00155	CbGeAlD
Sunitinib—CSNK2A1—Signaling by Wnt—MEN1—duodenum cancer	0.000197	0.0146	CbGpPWpGaD
Sunitinib—HIPK2—Generic Transcription Pathway—MEN1—duodenum cancer	0.000197	0.0146	CbGpPWpGaD
Sunitinib—JAK2—lymph node—duodenum cancer	0.000196	0.00153	CbGeAlD
Sunitinib—RPS6KA3—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.000195	0.0144	CbGpPWpGaD
Sunitinib—PDGFRB—endocrine gland—duodenum cancer	0.000194	0.00151	CbGeAlD
Sunitinib—FYN—lymph node—duodenum cancer	0.000194	0.00151	CbGeAlD
Sunitinib—CSNK1A1—Signaling by WNT in cancer—MEN1—duodenum cancer	0.000191	0.0141	CbGpPWpGaD
Sunitinib—MAP3K3—lymph node—duodenum cancer	0.000189	0.00148	CbGeAlD
Sunitinib—MAP4K5—lymph node—duodenum cancer	0.000189	0.00148	CbGeAlD
Sunitinib—ABCC4—digestive system—duodenum cancer	0.000187	0.00146	CbGeAlD
Sunitinib—FLT1—lymph node—duodenum cancer	0.000183	0.00143	CbGeAlD
Sunitinib—EPHB6—lymph node—duodenum cancer	0.000181	0.00141	CbGeAlD
Sunitinib—ABCC2—digestive system—duodenum cancer	0.000181	0.00141	CbGeAlD
Sunitinib—YES1—lymph node—duodenum cancer	0.000175	0.00137	CbGeAlD
Sunitinib—STK10—lymph node—duodenum cancer	0.000173	0.00135	CbGeAlD
Sunitinib—TAOK3—lymph node—duodenum cancer	0.000173	0.00135	CbGeAlD
Sunitinib—CSNK1E—TCF dependent signaling in response to WNT—MEN1—duodenum cancer	0.000171	0.0127	CbGpPWpGaD
Sunitinib—PDGFRA—lymph node—duodenum cancer	0.000171	0.00134	CbGeAlD
Sunitinib—CSNK1E—RNF mutants show enhanced WNT signaling and proliferation—MEN1—duodenum cancer	0.000166	0.0123	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling by Wnt—MEN1—duodenum cancer	0.000157	0.0117	CbGpPWpGaD
Sunitinib—MAP2K5—lymph node—duodenum cancer	0.000155	0.00121	CbGeAlD
Sunitinib—KDR—lymph node—duodenum cancer	0.000155	0.00121	CbGeAlD
Sunitinib—ABCC4—endocrine gland—duodenum cancer	0.000154	0.0012	CbGeAlD
Sunitinib—CSNK1E—Signaling by WNT in cancer—MEN1—duodenum cancer	0.000154	0.0114	CbGpPWpGaD
Sunitinib—CSF1R—lymph node—duodenum cancer	0.000151	0.00118	CbGeAlD
Sunitinib—ABCC2—endocrine gland—duodenum cancer	0.000149	0.00117	CbGeAlD
Sunitinib—PRPF4—Gene Expression—MEN1—duodenum cancer	0.000147	0.0109	CbGpPWpGaD
Sunitinib—CYP3A5—pancreas—duodenum cancer	0.000143	0.00112	CbGeAlD
Sunitinib—KIT—lymph node—duodenum cancer	0.000137	0.00107	CbGeAlD
Sunitinib—PDGFRB—lymph node—duodenum cancer	0.000134	0.00105	CbGeAlD
Sunitinib—LATS2—Signaling Pathways—GAST—duodenum cancer	0.00013	0.00961	CbGpPWpGaD
Sunitinib—TYK2—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.000129	0.00955	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling by Wnt—MEN1—duodenum cancer	0.000127	0.00942	CbGpPWpGaD
Sunitinib—LATS2—Signaling Pathways—SCT—duodenum cancer	0.000123	0.00911	CbGpPWpGaD
Sunitinib—KCNH2—endocrine gland—duodenum cancer	0.000122	0.000956	CbGeAlD
Sunitinib—CYP3A5—digestive system—duodenum cancer	0.000122	0.000955	CbGeAlD
Sunitinib—KCNH2—SIDS Susceptibility Pathways—SST—duodenum cancer	0.000116	0.00863	CbGpPWpGaD
Sunitinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.000109	0.00809	CbGpPWpGaD
Sunitinib—LATS2—Signaling Pathways—MEN1—duodenum cancer	0.000107	0.00796	CbGpPWpGaD
Sunitinib—ABCC4—lymph node—duodenum cancer	0.000107	0.000833	CbGeAlD
Sunitinib—ABCC2—lymph node—duodenum cancer	0.000103	0.000806	CbGeAlD
Sunitinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.000102	0.00757	CbGpPWpGaD
Sunitinib—CYP3A5—endocrine gland—duodenum cancer	0.000101	0.000789	CbGeAlD
Sunitinib—STK4—Signaling Pathways—GAST—duodenum cancer	9.82e-05	0.00728	CbGpPWpGaD
Sunitinib—JAK2—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	9.77e-05	0.00724	CbGpPWpGaD
Sunitinib—HIPK2—Gene Expression—MEN1—duodenum cancer	9.49e-05	0.00703	CbGpPWpGaD
Sunitinib—STK4—Signaling Pathways—SCT—duodenum cancer	9.31e-05	0.0069	CbGpPWpGaD
Sunitinib—CYP3A4—digestive system—duodenum cancer	9.18e-05	0.000717	CbGeAlD
Sunitinib—LATS2—Signaling Pathways—SST—duodenum cancer	8.89e-05	0.00658	CbGpPWpGaD
Sunitinib—PHKG1—Disease—MEN1—duodenum cancer	8.81e-05	0.00653	CbGpPWpGaD
Sunitinib—KCNH2—lymph node—duodenum cancer	8.46e-05	0.000661	CbGeAlD
Sunitinib—STK3—Signaling Pathways—GAST—duodenum cancer	8.35e-05	0.00619	CbGpPWpGaD
Sunitinib—CSNK1G2—Disease—MEN1—duodenum cancer	8.28e-05	0.00614	CbGpPWpGaD
Sunitinib—GRK1—Disease—MEN1—duodenum cancer	8.28e-05	0.00614	CbGpPWpGaD
Sunitinib—STK4—Signaling Pathways—MEN1—duodenum cancer	8.14e-05	0.00603	CbGpPWpGaD
Sunitinib—STK3—Signaling Pathways—SCT—duodenum cancer	7.92e-05	0.00587	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling by GPCR—GAST—duodenum cancer	7.87e-05	0.00583	CbGpPWpGaD
Sunitinib—ABCB1—pancreas—duodenum cancer	7.61e-05	0.000594	CbGeAlD
Sunitinib—MAP3K7—Signaling by Wnt—MEN1—duodenum cancer	7.59e-05	0.00563	CbGpPWpGaD
Sunitinib—CYP3A4—endocrine gland—duodenum cancer	7.58e-05	0.000592	CbGeAlD
Sunitinib—ABCG2—lymph node—duodenum cancer	7.53e-05	0.000588	CbGeAlD
Sunitinib—PHKG2—Disease—MEN1—duodenum cancer	7.49e-05	0.00555	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling by GPCR—SCT—duodenum cancer	7.46e-05	0.00553	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling by GPCR—GAST—duodenum cancer	7.07e-05	0.00524	CbGpPWpGaD
Sunitinib—CSNK1G2—Signaling Pathways—GAST—duodenum cancer	7e-05	0.00519	CbGpPWpGaD
Sunitinib—GRK1—Signaling Pathways—GAST—duodenum cancer	7e-05	0.00519	CbGpPWpGaD
Sunitinib—STK3—Signaling Pathways—MEN1—duodenum cancer	6.92e-05	0.00513	CbGpPWpGaD
Sunitinib—STK4—Signaling Pathways—SST—duodenum cancer	6.73e-05	0.00499	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling by GPCR—SCT—duodenum cancer	6.7e-05	0.00496	CbGpPWpGaD
Sunitinib—CSNK1G2—Signaling Pathways—SCT—duodenum cancer	6.64e-05	0.00492	CbGpPWpGaD
Sunitinib—GRK1—Signaling Pathways—SCT—duodenum cancer	6.64e-05	0.00492	CbGpPWpGaD
Sunitinib—AXL—Signaling Pathways—GAST—duodenum cancer	6.64e-05	0.00492	CbGpPWpGaD
Sunitinib—CSNK2A1—Disease—MEN1—duodenum cancer	6.57e-05	0.00487	CbGpPWpGaD
Sunitinib—ABCB1—digestive system—duodenum cancer	6.5e-05	0.000507	CbGeAlD
Sunitinib—AXL—Signaling Pathways—SCT—duodenum cancer	6.29e-05	0.00466	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—GAST—duodenum cancer	6.07e-05	0.0045	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—GAST—duodenum cancer	5.84e-05	0.00433	CbGpPWpGaD
Sunitinib—GRK1—Signaling Pathways—MEN1—duodenum cancer	5.8e-05	0.0043	CbGpPWpGaD
Sunitinib—CSNK1G2—Signaling Pathways—MEN1—duodenum cancer	5.8e-05	0.0043	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—SCT—duodenum cancer	5.75e-05	0.00426	CbGpPWpGaD
Sunitinib—STK3—Signaling Pathways—SST—duodenum cancer	5.73e-05	0.00424	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling by GPCR—GAST—duodenum cancer	5.63e-05	0.00417	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—GAST—duodenum cancer	5.55e-05	0.00411	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—GAST—duodenum cancer	5.55e-05	0.00411	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—SCT—duodenum cancer	5.54e-05	0.0041	CbGpPWpGaD
Sunitinib—AXL—Signaling Pathways—MEN1—duodenum cancer	5.5e-05	0.00407	CbGpPWpGaD
Sunitinib—ROCK1—GPCR downstream signaling—GAST—duodenum cancer	5.47e-05	0.00405	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling by GPCR—SST—duodenum cancer	5.39e-05	0.00399	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—GAST—duodenum cancer	5.38e-05	0.00399	CbGpPWpGaD
Sunitinib—ABCB1—endocrine gland—duodenum cancer	5.37e-05	0.000419	CbGeAlD
Sunitinib—RPS6KA3—Signaling by GPCR—SCT—duodenum cancer	5.34e-05	0.00395	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—SCT—duodenum cancer	5.26e-05	0.0039	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—SCT—duodenum cancer	5.26e-05	0.0039	CbGpPWpGaD
Sunitinib—CSNK1A1—Disease—MEN1—duodenum cancer	5.24e-05	0.00388	CbGpPWpGaD
Sunitinib—ROCK1—GPCR downstream signaling—SCT—duodenum cancer	5.19e-05	0.00384	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—SCT—duodenum cancer	5.1e-05	0.00378	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—MEN1—duodenum cancer	5.03e-05	0.00373	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—GAST—duodenum cancer	4.97e-05	0.00368	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—GAST—duodenum cancer	4.97e-05	0.00368	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling by GPCR—SST—duodenum cancer	4.84e-05	0.00359	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—MEN1—duodenum cancer	4.84e-05	0.00359	CbGpPWpGaD
Sunitinib—CSNK1G2—Signaling Pathways—SST—duodenum cancer	4.8e-05	0.00356	CbGpPWpGaD
Sunitinib—GRK1—Signaling Pathways—SST—duodenum cancer	4.8e-05	0.00356	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—SCT—duodenum cancer	4.71e-05	0.00349	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—SCT—duodenum cancer	4.71e-05	0.00349	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—GAST—duodenum cancer	4.7e-05	0.00348	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—GAST—duodenum cancer	4.65e-05	0.00344	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—MEN1—duodenum cancer	4.6e-05	0.00341	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—MEN1—duodenum cancer	4.6e-05	0.00341	CbGpPWpGaD
Sunitinib—AXL—Signaling Pathways—SST—duodenum cancer	4.55e-05	0.00337	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—MEN1—duodenum cancer	4.46e-05	0.00331	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—SCT—duodenum cancer	4.45e-05	0.0033	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—GAST—duodenum cancer	4.43e-05	0.00328	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—SCT—duodenum cancer	4.41e-05	0.00326	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—MEN1—duodenum cancer	4.23e-05	0.00314	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—SCT—duodenum cancer	4.2e-05	0.00311	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—GAST—duodenum cancer	4.17e-05	0.00309	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—SST—duodenum cancer	4.16e-05	0.00308	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—GAST—duodenum cancer	4.14e-05	0.00307	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—MEN1—duodenum cancer	4.12e-05	0.00305	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—SST—duodenum cancer	4e-05	0.00297	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—SCT—duodenum cancer	3.96e-05	0.00293	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—SCT—duodenum cancer	3.93e-05	0.00291	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—MEN1—duodenum cancer	3.89e-05	0.00288	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling by GPCR—SST—duodenum cancer	3.86e-05	0.00286	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—MEN1—duodenum cancer	3.85e-05	0.00285	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—SST—duodenum cancer	3.8e-05	0.00282	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—SST—duodenum cancer	3.8e-05	0.00282	CbGpPWpGaD
Sunitinib—ROCK1—GPCR downstream signaling—SST—duodenum cancer	3.75e-05	0.00278	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—GAST—duodenum cancer	3.73e-05	0.00276	CbGpPWpGaD
Sunitinib—ABCB1—lymph node—duodenum cancer	3.71e-05	0.00029	CbGeAlD
Sunitinib—PAK3—Signaling Pathways—SST—duodenum cancer	3.69e-05	0.00273	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—MEN1—duodenum cancer	3.67e-05	0.00272	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—GAST—duodenum cancer	3.58e-05	0.00265	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—SCT—duodenum cancer	3.54e-05	0.00262	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—MEN1—duodenum cancer	3.46e-05	0.00256	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—MEN1—duodenum cancer	3.43e-05	0.00254	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—SST—duodenum cancer	3.41e-05	0.00252	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—SST—duodenum cancer	3.4e-05	0.00252	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—SCT—duodenum cancer	3.39e-05	0.00251	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—GAST—duodenum cancer	3.36e-05	0.00249	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—GAST—duodenum cancer	3.33e-05	0.00246	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—SST—duodenum cancer	3.22e-05	0.00238	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—SST—duodenum cancer	3.18e-05	0.00236	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—SCT—duodenum cancer	3.18e-05	0.00236	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—GAST—duodenum cancer	3.16e-05	0.00234	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—SCT—duodenum cancer	3.15e-05	0.00234	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—GAST—duodenum cancer	3.11e-05	0.00231	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—GAST—duodenum cancer	3.05e-05	0.00226	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—SST—duodenum cancer	3.03e-05	0.00225	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—SCT—duodenum cancer	3e-05	0.00222	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—MEN1—duodenum cancer	2.96e-05	0.0022	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—GAST—duodenum cancer	2.96e-05	0.00219	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—SCT—duodenum cancer	2.95e-05	0.00219	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—GAST—duodenum cancer	2.94e-05	0.00217	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—GAST—duodenum cancer	2.92e-05	0.00216	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—SCT—duodenum cancer	2.89e-05	0.00214	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—SST—duodenum cancer	2.86e-05	0.00212	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—SST—duodenum cancer	2.84e-05	0.0021	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—GAST—duodenum cancer	2.83e-05	0.0021	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—GAST—duodenum cancer	2.83e-05	0.0021	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—GAST—duodenum cancer	2.83e-05	0.00209	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—SCT—duodenum cancer	2.8e-05	0.00208	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—SCT—duodenum cancer	2.78e-05	0.00206	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—MEN1—duodenum cancer	2.78e-05	0.00206	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—SCT—duodenum cancer	2.76e-05	0.00205	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—GAST—duodenum cancer	2.76e-05	0.00204	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—MEN1—duodenum cancer	2.76e-05	0.00204	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—SCT—duodenum cancer	2.68e-05	0.00199	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—SCT—duodenum cancer	2.68e-05	0.00199	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—SCT—duodenum cancer	2.68e-05	0.00199	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—SCT—duodenum cancer	2.61e-05	0.00194	CbGpPWpGaD
Sunitinib—TYK2—Disease—MEN1—duodenum cancer	2.61e-05	0.00193	CbGpPWpGaD
Sunitinib—FGFR2—Disease—MEN1—duodenum cancer	2.57e-05	0.00191	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—SST—duodenum cancer	2.56e-05	0.00189	CbGpPWpGaD
Sunitinib—KIT—Disease—MEN1—duodenum cancer	2.53e-05	0.00187	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—MEN1—duodenum cancer	2.52e-05	0.00187	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—SST—duodenum cancer	2.45e-05	0.00182	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—MEN1—duodenum cancer	2.43e-05	0.0018	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—MEN1—duodenum cancer	2.42e-05	0.00179	CbGpPWpGaD
Sunitinib—FGFR1—Disease—MEN1—duodenum cancer	2.4e-05	0.00178	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—MEN1—duodenum cancer	2.39e-05	0.00177	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—GAST—duodenum cancer	2.39e-05	0.00177	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—MEN1—duodenum cancer	2.34e-05	0.00174	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—MEN1—duodenum cancer	2.34e-05	0.00174	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—SST—duodenum cancer	2.3e-05	0.0017	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—MEN1—duodenum cancer	2.28e-05	0.00169	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—SST—duodenum cancer	2.28e-05	0.00169	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—GAST—duodenum cancer	2.27e-05	0.00168	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—SCT—duodenum cancer	2.27e-05	0.00168	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—MEN1—duodenum cancer	2.21e-05	0.00164	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—GAST—duodenum cancer	2.2e-05	0.00163	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—GAST—duodenum cancer	2.18e-05	0.00161	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—SST—duodenum cancer	2.17e-05	0.00161	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—MEN1—duodenum cancer	2.16e-05	0.0016	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—SCT—duodenum cancer	2.15e-05	0.00159	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—GAST—duodenum cancer	2.14e-05	0.00158	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—GAST—duodenum cancer	2.14e-05	0.00158	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—SST—duodenum cancer	2.13e-05	0.00158	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—SCT—duodenum cancer	2.09e-05	0.00155	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—SST—duodenum cancer	2.09e-05	0.00155	CbGpPWpGaD
Sunitinib—FYN—Disease—MEN1—duodenum cancer	2.08e-05	0.00154	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—MEN1—duodenum cancer	2.07e-05	0.00153	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—SCT—duodenum cancer	2.06e-05	0.00153	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—GAST—duodenum cancer	2.03e-05	0.0015	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—SST—duodenum cancer	2.03e-05	0.0015	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—SCT—duodenum cancer	2.03e-05	0.0015	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—SCT—duodenum cancer	2.03e-05	0.0015	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—GAST—duodenum cancer	2.02e-05	0.0015	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—SST—duodenum cancer	2.01e-05	0.00149	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—SST—duodenum cancer	2e-05	0.00148	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MEN1—duodenum cancer	1.98e-05	0.00147	CbGpPWpGaD
Sunitinib—JAK2—Disease—MEN1—duodenum cancer	1.98e-05	0.00146	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—SST—duodenum cancer	1.94e-05	0.00144	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—SST—duodenum cancer	1.94e-05	0.00144	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—SST—duodenum cancer	1.94e-05	0.00144	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—SCT—duodenum cancer	1.92e-05	0.00142	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—SCT—duodenum cancer	1.92e-05	0.00142	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—SST—duodenum cancer	1.89e-05	0.0014	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MEN1—duodenum cancer	1.88e-05	0.00139	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—GAST—duodenum cancer	1.87e-05	0.00138	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MEN1—duodenum cancer	1.83e-05	0.00135	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—GAST—duodenum cancer	1.82e-05	0.00135	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MEN1—duodenum cancer	1.8e-05	0.00134	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MEN1—duodenum cancer	1.77e-05	0.00131	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MEN1—duodenum cancer	1.77e-05	0.00131	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—SCT—duodenum cancer	1.77e-05	0.00131	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—GAST—duodenum cancer	1.76e-05	0.0013	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—GAST—duodenum cancer	1.75e-05	0.00129	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—SCT—duodenum cancer	1.73e-05	0.00128	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MEN1—duodenum cancer	1.68e-05	0.00125	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MEN1—duodenum cancer	1.68e-05	0.00124	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—GAST—duodenum cancer	1.67e-05	0.00124	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—SCT—duodenum cancer	1.67e-05	0.00123	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—SCT—duodenum cancer	1.66e-05	0.00123	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—SST—duodenum cancer	1.64e-05	0.00122	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—SCT—duodenum cancer	1.58e-05	0.00117	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—SST—duodenum cancer	1.56e-05	0.00115	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MEN1—duodenum cancer	1.55e-05	0.00115	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—SST—duodenum cancer	1.51e-05	0.00112	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MEN1—duodenum cancer	1.51e-05	0.00112	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—SST—duodenum cancer	1.49e-05	0.0011	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—SST—duodenum cancer	1.46e-05	0.00109	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—SST—duodenum cancer	1.46e-05	0.00109	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MEN1—duodenum cancer	1.46e-05	0.00108	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MEN1—duodenum cancer	1.45e-05	0.00107	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—SST—duodenum cancer	1.39e-05	0.00103	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—SST—duodenum cancer	1.39e-05	0.00103	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MEN1—duodenum cancer	1.38e-05	0.00103	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—SST—duodenum cancer	1.28e-05	0.000948	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—SST—duodenum cancer	1.25e-05	0.000925	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—SST—duodenum cancer	1.2e-05	0.000892	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—SST—duodenum cancer	1.2e-05	0.000887	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—SST—duodenum cancer	1.14e-05	0.000848	CbGpPWpGaD
